Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
Sales | 620 | 424 | 190 | 257 | 425 |
Gross Profit | 620 | 424 | 190 | 257 | 425 |
Operating Expenses | 4,225 | 4,737 | 7,535 | 6,497 | 5,067 |
Operating Income | -3,605 | -4,313 | -7,345 | -6,240 | -4,642 |
Interest Expense | 186 | -58 | 134 | 66 | 10 |
Other Income | 27 | 4 | 0 | 0 | -158 |
Pre-tax Income | -3,764 | -4,252 | -7,478 | -6,307 | -4,810 |
Net Income Continuous | -3,764 | -4,252 | -7,478 | -6,307 | -4,810 |
Net Income | $-3,764 | $-4,252 | $-7,478 | $-6,307 | $-4,810 |
EPS Basic Total Ops | -3.56 | -11.18 | -23.61 | -19.49 | -15.65 |
EPS Basic Continuous Ops | -3.30 | -10.68 | -23.95 | -19.97 | -16.70 |
EPS Diluted Total Ops | -3.56 | -11.18 | -23.61 | -19.49 | -15.65 |
EPS Diluted Continuous Ops | -3.30 | -10.68 | -23.95 | -19.97 | -16.70 |
EPS Diluted Before Non-Recurring Items | -5.00 | -11.20 | -23.60 | N/A | N/A |
EBITDA(a) | $-3,523 | $-5,819 | $-5,676 | $-6,146 | $-4,550 |